3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
5
Multiple Myeloma
4
Barrett Esophagus
3
Venous Thromboembolism
2
Tobacco Use Disorder
2
Prostatic Neoplasms
2
Precancerous Conditions
2
Polycythemia Vera
2
Myocardial Infarction
2
Esophageal Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms
2
Vascular Diseases
1
Triple Negative Breast Neoplasms
1
Thromboembolism
1
Thrombocytopenia
1
Thrombocythemia, Essential
1
Stroke
1
Soft Tissue Neoplasms
1
Smoking Cessation
1
Sarcoma
1
Rectal Neoplasms
1
Ovarian Neoplasms
1
Node Positive HER2 Negative Breast Cancer
1
Neoplasms, Plasma Cell
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Myocardial Ischemia
1
Myeloproliferative Disorders
1
Multiple Pulmonary Nodules
1
Interventions
Cisplatin
32
human papillomavirus vaccine, L1 type 16, 18
16
Brachytherapy
15
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
12
Paclitaxel
11
Bevacizumab
11
pembrolizumab
10
Platinum
9
1,2-diaminocyclohexaneplatinum II citrate
9
Topotecan
8
Radiotherapy, Intensity-Modulated
8
Radiation
8
Papillomavirus Vaccines
8
atezolizumab
6
Gemcitabine
6
Fluorodeoxyglucose F18
6
Cyclophosphamide
6
tisotumab vedotin
5
fludarabine phosphate
5
fludarabine
5
aldesleukin
5
Taxes
5
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Carboplatin
5
Vaccines, Synthetic
4
Nivolumab
4
Immunoglobulin G
4
Disulfides
4
Colposcopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Uterine Cervical Neoplasms
×
Aspirin
×
Clear all
No trials found.